# OpenAI has launched a new artificial intelligence model designed to support research across biology, drug discovery, and translational medicine.

*genai · news · 2026-04-17 · Euronews*

## Key points

- OpenAI launched GPT‑Rosalind, a life sciences AI model optimized for biological and medical research tasks.
- GPT‑Rosalind excels at reasoning over molecules, proteins, genes, pathways, and disease-relevant biology.
- The model demonstrates advanced capabilities in multi-step scientific workflows, including experimental planning and data analysis.
- OpenAI is partnering with companies like Moderna, Amgen, and Novo Nordisk to deploy GPT‑Rosalind in R&D and manufacturing.
- Full integration of GPT‑Rosalind pilot programs with partners is targeted by the end of the year.

**Companies:** OpenAI, Moderna, Amgen, Thermo Fisher Scientific, Novo Nordisk, Allen Institute
**Countries:** United States, Denmark

[Read the full story on Euronews](https://www.euronews.com/health/2026/04/17/what-to-know-about-openais-new-model-for-life-sciences-research-gpt-rosalind)

---

Canonical: https://newsio.io/n/56d3b7a5-9683-4edf-89bf-b4e5418d05a6/openai-has-launched-a-new-artificial-intelligence-model-designed-to-support-rese
Summarized by Newsio from Euronews. https://newsio.io/how-it-works